FDA approves new schizophrenia treatment KarXT
The FDA has approved a groundbreaking new treatment, KarXT, for schizophrenia, which combines two drugs to reduce symptoms and side effects.
Ask our experts for help
The FDA has approved a groundbreaking new treatment, KarXT, for schizophrenia, which combines two drugs to reduce symptoms and side effects.
Should Adults be Forced to Get Vaccinated? Vaccine mandates balance personal freedom vs public health protection.
UCL’s DNA discovery and NIST’s SAC-IR imaging converge to revolutionize diabetes treatment with targeted treatments and improved outcomes.
A groundbreaking study published in Advanced Science has challenged a long-held theory on Parkinson’s disease protein aggregation, revealing that liquid-liquid phase separation (LLPS) may have a protective effect against protein aggregation rather than promoting it.
Scientists predict depression before it happens by analyzing brain scans.
Eluned Morgan’s “country-first” approach to reforming the Welsh NHS has sparked both praise and concern over its potential impact on other public services.
The article highlights artificial intelligence (AI) as a key ally in the battle against future pandemics by detecting early signs of outbreaks, predicting variant spread, and accelerating vaccine development, but notes challenges such as bias, data availability, and ethical use, requiring collaboration and equitable representation.
Smoking accelerates cognitive decline by up to 85% more than non-smoking lifestyles.